Methods and devices for providing prolonged drug therapy

Details for Australian Patent Application No. 2007237241 (hide)

Owner Alza Corporation

Inventors Weyers, Richard G.; Ayer, Atul D.; Wright, Jeri D.; Hamel, Lawrence G.; Lam, Andrew C.; Shivanand, Padmaja; Gupta, Suneel K.; Hatamkhany, Zahedeh; Guinta, Diane R.; Saks, Samuel R.; Christopher, Carol A.

Agent Shelston IP

Pub. Number AU-B-2007237241

Parent 2004201230

Filing date 28 November 2007

Wipo publication date 20 December 2007

Acceptance publication date 6 January 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

Event Publications

13 December 2007 Complete Application Filed

20 December 2007 Application Open to Public Inspection

  Published as AU-B-2007237241

6 January 2011 Application Accepted

  Published as AU-B-2007237241

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237242-A communication platform

2007237240-Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease